Sonia Singh
Internal Medicine · Houston, TXNPI 1255774097
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $562 and has fallen 92.5% since, to $42 in 2024.
Across 76 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valeritas, Inc.$176
- CSL Behring$84
- Novo Nordisk$73
- Amgen$68
- Acorda Therapeutics, Inc$66
- Chiesi USA, Inc.$64
- plus $669 from 24 others
What the payments were for
- Speaking & faculty fees$393%
- Food & beverage$1,16097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Valeritas, Inc. | 17 | $176 |
| CSL Behring | 5 | $84 |
| Novo Nordisk | 5 | $73 |
| Amgen | 4 | $68 |
| Acorda Therapeutics, Inc | 4 | $66 |
| Chiesi USA, Inc. | 4 | $64 |
| Pfizer | 4 | $62 |
| Novocure Inc. | 1 | $58 |
| Johnson & Johnson | 3 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $42 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
| Merck | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| AstraZeneca | 2 | $34 |
| EMD Serono, Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Mannkind Corporation | 2 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| AbbVie | 1 | $24 |
| Boston Scientific | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| UCB, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Insulet Corporation | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Biogen | 1 | $14 |
| Radius Health, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$1,199 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Houston
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
- Krina PatelHouston$255K
- Nicholas ShortHouston$247K
- Naveen PemmarajuHouston$230K
- Mariana Chavez MacgregorHouston$188K
- Shumei KatoHouston$180K
- Sukhdeep BasraHouston$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.